Why Imugene, Neuren, Sigma, and Smartgroup shares are charging higher

These shares are ending the week on a high. But why? Let's find out.

| More on:
A man clenches his fists in excitement as gold coins fall from the sky.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is having a great finish to the week. In afternoon trade, the benchmark index is up 0.9% to 8,299.4 points.

Four ASX shares that are rising more than most are listed below. Here's why they are charging higher:

Imugene Ltd (ASX: IMU)

The Imugene share price is up 4.5% to 4.7 cents. This morning, this clinical-stage immune-oncology company announced the opening of the first Australian site for its azer-cel phase 1b clinical trial. The release notes that the Royal Prince Alfred Hospital in Sydney will begin patient recruitment in November, marking another significant milestone in the development of its promising off-the-shelf allogeneic CAR Tcell therapy.

Neuren Pharmaceuticals Ltd (ASX: NEU)

The Neuren Pharmaceuticals share price is up 14% to $16.38. Investors have been buying this pharmaceuticals company's shares since the release of its third quarter update this week. Neuren revealed that Daybue net sales for the last nine months exceeded the full-year threshold of US$250 million for Neuren's first sales milestone income of US$50 million. In addition, third quarter royalty income came in at A$13.2 million, which brings the total to A$37.5 million year to date. Neuren also advised that it expects full year 2024 income to be A$216 million to A$218 million.

Sigma Healthcare Ltd (ASX: SIG)

The Sigma Healthcare share price is up 7% to $2.60. This pharmacy chain operator and wholesale distributor's shares have been on fire this week after the ACCC approved its merger with Chemist Warehouse. Sigma's CEO, Vikesh Ramsunder, said: "The ACCC decision marks a critical milestone for the proposed transaction and provides us with the conviction to progress with the next steps in the process. The proposed transaction has the potential to create a leading ASX listed healthcare company through the combination of the complementary strengths of Sigma's state-of-the-art pharmaceutical distribution infrastructure with Chemist Warehouse Group's retailing know-how."

Smartgroup Corporation Ltd (ASX: SIQ)

The Smartgroup share price is up 4% to $7.98. Investors have been buying this salary packaging and fleet management company's shares following the release of a broker note out of Bell Potter. According to the note, the broker has reaffirmed its buy rating on its shares with an improved price target of $10.00. Bell Potter said: "Traditional volume drivers continue to demonstrate cooling in the broader auto market. Upon closer examination, we view SIQ as reasonable buying at the current levels and review key developments."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Smartgroup. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was another woeful day for investors this Wednesday.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Cedar Woods, Humm, Star, and Zip shares are storming higher today

These shares are having a better day than most on hump day. But why?

Read more »

bull market model with a bull looking at a rising chart
Opinions

By December 2026, $1,000 invested in EOS shares could be worth…

With its share price taking off and contracts piling up, EOS is shaping up as one of the most compelling…

Read more »

Army man and woman on digital devices.
Share Gainers

Guess which ASX 300 defence stock has already rocketed 51% this week (Hint, not DroneShield)

Investors have sent this ASX 300 defence stock flying this week. But why?

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Share Gainers

Why 4DMedical, DroneShield, EOS, and Star shares are rising today

These shares are catching the eye on Tuesday. But why?

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield kind of Monday for investors.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why 4DMedical, EOS, Gorilla Gold, and Neuren shares are racing higher today

These shares are starting the week with a bang. Here's why.

Read more »